In this vein, CAIX IHC-based overexpression in OSCC has been frequently correlated with parameters such as lymph node involvement, larger tumor size, advanced clinical stage, poor differentiation, lack of response to treatment, or poorer long-term outcomes (i.e., DFS and OS) [20]. The gene discussed is CA9; the disease is neoplasm.